1. Aliev G., Li Y., Palacios H., and Obrenovich M.E. Oxidative Stress Induced Mitochondrial DNA Deletion as a Hallmark for the Drug Development in the Context of the Cerebrovascular Diseases. Recent Patents on Cardiovascular Drug Discovery, 2011, 6, 222-241.
2. Aliev G. Oxidative stress induced-metabolic imbalance, mitochondrial failure, and cellular hypoperfusion as primary pathogenetic factors for the development of Alzheimer disease which can be used as a alternate and successful drug treatment strategy: past, present and future. CNS & Neurological Disorders – Drug Targets, 2011;10(2):147-8.
3. Palacios H.H., Yendluri B.B., Parvathaneni K. , Shadlinski V. B. , Obrenovich M. E., Leszek J., Gokhman D. , Gąsiorowski K. Bragin V. and Aliev G. Mitochondrion-Specific Antioxidants as Drug Treatments for Alzheimer Disease. CNS & Neurological Disorders – Drug Targets, 2011;10(2):149-62.
4. Aliev, G. Palacios H.H., Cacabelos P., Cacabelos R., Burzynski G., and S.R. Burzynski. Mitochondria Specific Antioxidants and their Derivatives in the Context of the Drug Development for Neurodegeneration and Cancer. Drug Des 2012, 2: 103, doi: 10.4172/2169-0138.1000103.
5. Aliev, G., Obrenovich M.E., Tabrez S., Jabir N.R., Reddy V.P., Li Y., Burnstock G., Cacabelos R. and Kamal M.A. Link between Cancer and Alzheimer Disease via Oxidative Stress Induced by Nitric Oxide-Dependent Mitochondrial DNA Overproliferation and Deletion. Oxidative Medicine and Cellular Longevity. vol. 2013, Article ID 962984, 19 pages, 2013. doi:10.1155/2013/962984.
6. Aliev, G. “The Role of Oxidative Stress, Mitochondria Failure, and Cellular Hypoperfusion in the Context of Alzheimer Disease: Past, Present and Future”. Monograph Book: Nova Science Publishers, Inc., New York, 2013, ISBN: 978-1-61942-878-2. PP. 1-426. https://www.novapublishers.com/catalog/product_info.php?products_id=31801.
7. Aliev G., K. Shahida, C.K. Hua Gan S.K. Firoz, A. Khan, A.M. Abuzenadah, W. Kamal, M.A. Kamal, Tan Y., Qu X and M. Reale. Alzheimer disease and type 2 diabetes mellitus: the link to tyrosine hydroxylase and probable nutritional strategies. CNS & Neurological Disorders-Drug Targets. 2014, 13 (3), 467-477.
8. Aliev G., Priyadarshini M., Reddy V.P., Grieg N.H., Kaminsky Y., Cacabelos R. Ashraf G.Md., Jabir, N.R. , Kamal M.A., Nikolenko V.N., Zamyatnin Jr. A.A., Benberin V.V., and S. O. Bachurin. Oxidative Stress Mediated Mitochondrial and Vascular Lesions as Markers in the Pathogenesis of Alzheimer Disease. Current Medicinal Chemistry, 2014, 21, 2208-2217.
9. V.P. Reddy, J. Mehta and Aliev G. Role of α-Lipoic Acid and Acetyl-L-Carnitine in Dementia. In: Diet and Nutrition in Dementia and Cognitive Decline, 1st Edition (Eds. Colin R. Martin and Victor R. Preedy). Academic Press (Imprint of Elsevier). Print Book ISBN :9780124078246, eBook ISBN :9780124079397. Release Date: 18 Nov 2014 (2015), part V, Chapter 88, PP. 955-962. http://store.elsevier.com/product.jsp?isbn=9780124078246.
10. Shevtsova E.F., Vinogradova D.V., Kireeva E.G., V. Prakash Reddy, Aliev G. and Bachurin S.O. Dimebon Attenuates the Rat-Brain Mitochondrial Permeabilization. Curr Alzheimer Res. 2014;11(5):422-429.
11. Kosenko E. A., Beloushko E.E., Tikhonova L.A., V. P. Reddy, Aliev G., and Kaminsky Y.G. Differential Up-Regulation of Ammonia Detoxifying Enzymes in Cerebral Cortex, Cerebellum, Hippocampus, Striatum and Liver in Hyperammonemia. CNS Neurol Disord Drug Targets. 2014, 13(6):1089-1095.
12. Tikhonova L. A., Kaminsky Y. G., Li Y., Reddy V.P., Solomadin I. N., Kosenko E. A. and Aliev G. Impacts of Аβ25–35 on membrane stability, energy metabolic and antioxidant enzymes in erythrocytes of different ages. Am J Alzheimers Dis Other Demen. 2014, Vol. 29(8): 685-695 [Epub ahead of print, 2014 May 16. pii: 1533317514534757. ].